Connect with us

Health

The latest numbers on COVID-19 in Canada for Sunday, Feb. 7, 2021 – Burnaby Now

Published

 on


The latest numbers of confirmed COVID-19 cases in Canada as of 7:30 p.m. ET on Sunday Feb. 7, 2021.

There are 804,260 confirmed cases in Canada.

_ Canada: 804,260 confirmed cases (44,727 active, 738,766 resolved, 20,767 deaths).*The total case count includes 13 confirmed cases among repatriated travellers.

There were 3,203 new cases Sunday. The rate of active cases is 117.69 per 100,000 people. Over the past seven days, there have been a total of 24,407 new cases. The seven-day rolling average of new cases is 3,487.

There were 65 new reported deaths Sunday. Over the past seven days there have been a total of 735 new reported deaths. The seven-day rolling average of new reported deaths is 105. The seven-day rolling average of the death rate is 0.28 per 100,000 people. The overall death rate is 54.64 per 100,000 people. 

There have been zero tests completed.

_ Newfoundland and Labrador: 416 confirmed cases (19 active, 393 resolved, four deaths).

There was one new case Sunday. The rate of active cases is 3.64 per 100,000 people. Over the past seven days, there has been eight new case. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 0.77 per 100,000 people. 

There have been zero tests completed.

_ Prince Edward Island: 113 confirmed cases (three active, 110 resolved, zero deaths).

There were zero new cases Sunday. The rate of active cases is 1.88 per 100,000 people. Over the past seven days, there have been a total of two new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is zero per 100,000 people. 

There have been zero tests completed.

_ Nova Scotia: 1,585 confirmed cases (eight active, 1,512 resolved, 65 deaths).

There was one new case Sunday. The rate of active cases is 0.82 per 100,000 people. Over the past seven days, there has been five new case. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 6.64 per 100,000 people. 

There have been zero tests completed.

_ New Brunswick: 1,344 confirmed cases (204 active, 1,120 resolved, 20 deaths).

There were seven new cases Sunday. The rate of active cases is 26.1 per 100,000 people. Over the past seven days, there have been a total of 88 new cases. The seven-day rolling average of new cases is 13.

There were zero new reported deaths Sunday. Over the past seven days there have been a total of two new reported deaths. The seven-day rolling average of new reported deaths is zero. The seven-day rolling average of the death rate is 0.04 per 100,000 people. The overall death rate is 2.56 per 100,000 people. 

There have been zero tests completed.

_ Quebec: 270,058 confirmed cases (11,915 active, 248,112 resolved, 10,031 deaths).

There were 1,081 new cases Sunday. The rate of active cases is 138.96 per 100,000 people. Over the past seven days, there have been a total of 7,475 new cases. The seven-day rolling average of new cases is 1,068.

There were 32 new reported deaths Sunday. Over the past seven days there have been a total of 237 new reported deaths. The seven-day rolling average of new reported deaths is 34. The seven-day rolling average of the death rate is 0.39 per 100,000 people. The overall death rate is 116.99 per 100,000 people. 

There have been zero tests completed.

_ Ontario: 278,207 confirmed cases (14,799 active, 256,903 resolved, 6,505 deaths).

There were 1,489 new cases Sunday. The rate of active cases is 100.44 per 100,000 people. Over the past seven days, there have been a total of 9,996 new cases. The seven-day rolling average of new cases is 1,428.

There were 22 new reported deaths Sunday. Over the past seven days there have been a total of 317 new reported deaths. The seven-day rolling average of new reported deaths is 45. The seven-day rolling average of the death rate is 0.31 per 100,000 people. The overall death rate is 44.15 per 100,000 people. 

There have been zero tests completed.

_ Manitoba: 30,237 confirmed cases (3,256 active, 26,135 resolved, 846 deaths).

There were 79 new cases Sunday. The rate of active cases is 236.07 per 100,000 people. Over the past seven days, there have been a total of 673 new cases. The seven-day rolling average of new cases is 96.

There were four new reported deaths Sunday. Over the past seven days there have been a total of 17 new reported deaths. The seven-day rolling average of new reported deaths is two. The seven-day rolling average of the death rate is 0.18 per 100,000 people. The overall death rate is 61.34 per 100,000 people. 

There have been zero tests completed.

_ Saskatchewan: 25,403 confirmed cases (2,363 active, 22,701 resolved, 339 deaths).

There were 194 new cases Sunday. The rate of active cases is 200.48 per 100,000 people. Over the past seven days, there have been a total of 1,539 new cases. The seven-day rolling average of new cases is 220.

There were three new reported deaths Sunday. Over the past seven days there have been a total of 35 new reported deaths. The seven-day rolling average of new reported deaths is five. The seven-day rolling average of the death rate is 0.42 per 100,000 people. The overall death rate is 28.76 per 100,000 people. 

There have been zero tests completed.

_ Alberta: 126,767 confirmed cases (6,242 active, 118,816 resolved, 1,709 deaths).

There were 351 new cases Sunday. The rate of active cases is 141.16 per 100,000 people. Over the past seven days, there have been a total of 2,559 new cases. The seven-day rolling average of new cases is 366.

There were four new reported deaths Sunday. Over the past seven days there have been a total of 70 new reported deaths. The seven-day rolling average of new reported deaths is 10. The seven-day rolling average of the death rate is 0.23 per 100,000 people. The overall death rate is 38.65 per 100,000 people. 

There have been zero tests completed.

_ British Columbia: 69,716 confirmed cases (5,903 active, 62,567 resolved, 1,246 deaths).

There were zero new cases Sunday. The rate of active cases is 114.67 per 100,000 people. Over the past seven days, there have been a total of 2,056 new cases. The seven-day rolling average of new cases is 294.

There were zero new reported deaths Sunday. Over the past seven days there have been a total of 57 new reported deaths. The seven-day rolling average of new reported deaths is eight. The seven-day rolling average of the death rate is 0.16 per 100,000 people. The overall death rate is 24.2 per 100,000 people. 

There have been zero tests completed.

_ Yukon: 70 confirmed cases (zero active, 69 resolved, one deaths).

There were zero new cases Sunday. Over the past seven days, there have been a total of zero new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is 2.38 per 100,000 people. 

There have been zero tests completed.

_ Northwest Territories: 32 confirmed cases (one active, 31 resolved, zero deaths).

There were zero new cases Sunday. The rate of active cases is 2.21 per 100,000 people. Over the past seven days, there have been a total of one new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is zero per 100,000 people. 

There have been zero tests completed.

_ Nunavut: 299 confirmed cases (14 active, 284 resolved, one deaths).

There were zero new cases Sunday. The rate of active cases is 35.58 per 100,000 people. Over the past seven days, there have been a total of five new cases. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 2.54 per 100,000 people. 

There have been zero tests completed.

This report was automatically generated by The Canadian Press Digital Data Desk and was first published Feb. 7, 2021.

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

EU regulator backs month-long storage of Pfizer COVID-19 vaccine in fridges

Published

 on

Europe’s drug regulator on Monday recommended extending the storage time for the Pfizer-BioNTech COVID-19 vaccine at normal fridge temperatures to 31 days from five days, easing logistical challenges during rollouts in the region.

The change is applicable to unopened vials, the European Medicines Agency (EMA) said, adding that the advice by its human medicines committee came after assessing additional stability study data submitted by Pfizer and BioNTech.

“EMA is in continuous dialogue with the marketing authorisation holders of COVID-19 vaccines as they seek to make manufacturing improvements to enhance vaccine distribution in the EU,” the watchdog said.

The EU has allowed for ramped-up production of the Pfizer-BioNTech vaccine in the region and is eyeing a new deal to secure more doses of the shot after the bloc was hit by cuts in the supply of AstraZeneca’s vaccine.

Vaccine deliveries were also slower initially under the EU’s centralised procurement strategy.

U.S. authorities in February had approved storage and transport of the Pfizer-BioNTech vaccine at standard freezer temperatures of -15 to -25 degrees Celsius for up to two weeks instead of the ultra-cold temperatures between -80 to -60 degrees Celsius it usually requires.

The EU storage change also comes as the U.S. and German drugmakers are seeking approval of the vaccine for inoculating adolescents aged 12 to 15 years. The United States and Canada have started vaccinating this group with the shot, which uses the brand name Comirnaty.

The two-dose vaccine, similar to the one developed by Moderna, uses new mRNA technology to deliver instructions to the human body to build immunity against COVID-19.

With 200 million vaccine doses delivered overall, the EU is on track to achieve its goal of inoculating 70% of its adult population by summer, European Commission President Ursula von der Leyen tweeted on May 9.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan M. and Alex Richardson)

Continue Reading

Health

Sanofi-GSK report positive interim results for their COVID-19 shot

Published

 on

An experimental COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them to move to a late-stage study, the French drugmaker said on Monday.

Sanofi and Britain’s GSK said a global Phase III trial would start in the coming weeks and involve more than 35,000 adults, with the hope of seeing the vaccine approved by the fourth quarter after having initially targeted the first half of this year before a setback.

Sanofi and GSK last December were forced to restart their trial when the vaccine showed a low immune response in older adults as a result of a weak antigen formulation.

Sanofi and GSK shares were little changed in early trading.

“The Phase II interim results showed 95% to 100% seroconversion following a second injection in all age groups and across all doses, with acceptable tolerability and no safety concerns,” Sanofi said.

Seroconversion refers to the vaccine’s ability to prompt the body to produce antibodies against the coronavirus, as measured by blood readings. Later mass trials will be based on real infections.

“Interestingly, we also observed that our vaccine generated a higher antibody response in those with previous COVID-19 infection, we are analysing this further as it may suggest our vaccine could serve as a potential booster, regardless of what vaccine someone may have received (beforehand),” Su-Peing Ng, Sanofi’s global head of medical for vaccines, told reporters.

Ng said the vaccine had not been tested against so-called variants in the Phase II trial but that the Phase III study would be assessing it against various strains including a virus lineage known as B.1.351 first detected in South Africa.

But Sanofi, Ng said, has conducted parallel studies evaluating its vaccines against variants, with results expected to be published soon.

GSK and Sanofi’s vaccine candidate uses the same technology as one of Sanofi’s seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the shot, made by GSK.

‘QUITE A POTENTIAL’

Some 162.75 million people have been reported to be infected by the coronavirus in more than 210 countries and territories since the first cases were identified in China in December 2019, while economies have taken a hit and restrictions have turned daily life upside down.

The United States and Europe have embarked on mass vaccinations programmes in the past months, raising hopes of a gradual reopening, although the virus is still in circulation in many regions, with variants causing concern.

Last month, the European Union executive’s President Ursula von der Leyen said protein-based COVID-19 vaccines such as the one developed by Sanofi and GSK offered “quite a potential”, a positive signal as the bloc develops its purchasing strategy for the next two years.

Sanofi’s shot, however, even if approved, will come long after ones from Pfizer/BioNTech and Moderna, which have produced efficacy results of more than 90%.

So far, Sanofi has purchasing agreements with the United States, the EU, Britain and Canada, as well as with the World Health Organization-backed COVAX facility.

The company has pledged to help other drugmakers this year, striking “fill and finish” deals for vaccines made by Pfizer/BioNTech, Moderna and Johnson & Johnson.

In addition to its vaccine project in collaboration with GSK, Sanofi is working on a mRNA candidate with U.S. company Translate Bio for which it has started clinical trials.

 

(Reporting by Matthias Blamont; editing by Louise Heavens and Jason Neely)

Continue Reading

Health

Worldwide coronavirus cases cross 161.42 million, death toll at 3,488,751

Published

 on

More than 161.42 million people have been reported to be infected by the novel coronavirus globally and 3,488,751​ have died, according to a Reuters tally.

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

Interactive graphic tracking global spread of coronavirus: open https://tmsnrt.rs/2FThSv7 in an external browser.

Eikon users can click  for a case tracker.

The following table lists the top 50 countries by the number of reported cases. A complete list is available with the above links.

COUNTRIES AND TOTAL DEATHS CONFIRMED DEATHS PER

TERRITORIES CASES 10,000

INHABITANTS

United States 584,768 32,926,288 17.9

India 262,317 24,046,809 1.94

Brazil 430,417 15,433,989 20.55

France 107,423 5,848,154 16.04

Turkey 44,301 5,095,390 5.38

Russia 254,590 4,922,901 17.62

United Kingdom 127,668 4,446,824 19.21

Italy 123,927 4,146,722 20.51

Spain 79,339 3,604,799 16.95

Germany 85,903 3,579,871 10.36

Argentina 69,254 3,242,103 15.56

Colombia 79,760 3,067,879 16.06

Poland 71,311 2,849,014 18.78

Iran 76,433 2,732,152 9.34

Mexico 219,901 2,375,115 17.43

Ukraine 47,620 2,143,448 10.67

Peru 65,316 1,873,316 20.02

Indonesia 47,823 1,734,285 1.79

Czech Republic 29,857 1,651,178 28.09

South Africa 55,012 1,605,252 9.52

Netherlands 17,423 1,589,282 10.11

Canada 24,825 1,312,408 6.7

Chile 27,520 1,266,601 14.69

Iraq 15,910 1,134,859 4.14

Philippines 18,958 1,131,467 1.78

Romania 29,413 1,070,605 15.11

Sweden 14,275 1,037,126 14.03

Belgium 24,645 1,026,473 21.56

Pakistan 19,384 873,220 0.91

Portugal 16,999 841,379 16.53

Israel 6,379 839,076 7.18

Hungary 29,041 796,390 29.71

Bangladesh 12,102 779,535 0.75

Jordan 9,203 722,754 9.24

Serbia 6,646 705,185 9.52

Switzerland 10,179 679,510 11.96

Japan 11,396 673,821 0.9

Austria 10,455 635,780 11.83

United Arab Emirates 1,626 543,610 1.69

Lebanon 7,569 534,968 11.05

Morocco 9,091 514,670 2.52

Malaysia 1,822 462,190 0.58

Nepal 4,669 439,658 1.66

Saudi Arabia 7,134 431,432 2.12

Bulgaria 17,194 413,320 24.48

Ecuador 19,442 405,783 11.38

Slovakia 12,168 387,162 22.34

Greece 11,322 373,881 10.55

Belarus 2,681 373,351 2.83

Panama 6,288 369,455 15.05

Source: Reuters tally based on statements from health ministries and government officials

Generated at 10:00 GMT.

 

(Editing by David Clarke)

Continue Reading

Trending